Keywords Lobular breast cancer cyclin-dependent kinase 4/6 inhibitor abemaciclib ribociclib palbociclib real-world outcomes Get full text access Log in, subscribe or purchase for full access. REFERENCES 1. Tan, P.H. ∙ Ellis, I. ∙ Allison, K. ... The 2019 World Health Organization classification of tumours of the breast Histopathology. 2020; 77(2):181-185 2. Weigelt, B. ∙ Horlings, H.M. ∙ Kreike, B. ...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile